Abstract
Risk factors for development of intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) may differ between those who acquire the organism via patient-to-patient transmission versus by antibiotic selective pressure. The aim of this study was to quantify potential risk factors for the development of IRPA not due to patient-to-patient transmission.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
Cohort Studies
-
Cross Infection / epidemiology
-
Cross Infection / transmission*
-
Female
-
Humans
-
Imipenem / therapeutic use*
-
Intensive Care Units*
-
Intestines / microbiology
-
Male
-
Middle Aged
-
Prospective Studies
-
Pseudomonas Infections / epidemiology
-
Pseudomonas Infections / transmission*
-
Pseudomonas aeruginosa / isolation & purification*
-
Risk Factors
-
beta-Lactam Resistance*
Substances
-
Anti-Bacterial Agents
-
Imipenem